Small-cell lung cancer grows faster. Small-cell lung cancer spreads quicker. Small-cell lung cancer responds well tochemotherapyandradiation therapy. Small-cell lung cancer is most often linked to paraneoplastic syndromes, a group of symptoms that happen when the tumor makes hormone-like chemicals. ...
Small-cell lung cancer grows rapidly. The time from the development of symptoms of SCLC to diagnosis is usually 90 days or less. Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts ...
Small-Cell Lung Cancer Symptoms People with small-cell lung cancer typically have symptoms for about 2 to 3 months before they visit their doctor. The symptoms can result from local growth of the tumor (meaning growth in the lung where it started), spread to nearby areas, distant spread, pa...
小细胞肺癌(small cell lung cancer) Type Small cell lung cancer is one of the basic types of lung cancer. It belongs to undifferentiated carcinoma, and its pathological types include oat cell type, intermediate cell type and mixed oat cell type. 1/5 of lung cancer patients belong to this ...
Symptoms of metastatic disease may include anorexia, bone pain, fatigue, headache, and seizures. Small cell lung cancer patients rarely survive more than a few months without treatment [3]. In patients without extensive tumor spread (limited disease) at the time of diagnosis, median overall...
Learn about the signs & symptoms of small cell lung cancer (SCLC), also known as oat cell carcinoma. See full safety for more information.
Small-cell lung cancer (SCLC) is the most aggressive histologic type, with a 5-year survival <10%. SCLC is closely associated with tobacco consumption and infrequent in never-smokers. We aim to describe SCLC characteristics in never-smokers recruited in a radon-prone area. Patients and methods...
Find out about TECENTRIQ® (atezolizumab) for the treatment of extensive-stage small cell lung cancer (ES-SCLC). See full safety for more information.
To the cancer cell lines depicted in FIG.4, either PNC-27 or PNC-28 in varying doses were administered to the cancer cells. Cancer cell lines tested include: Rat Pancreatic cancer, Rat Brain Angiosarcoma, Mouse Melanoma, Cervical Squamous Cell Cancer, Non-small cell Lung Cancer (both with ...
Combination chemotherapy, generally platinum-based plus etoposide or irinotecan, is the mainstay first-line treatment for metastatic small-cell lung cancer. For non-metastatic disease, evidence supports early concurrent thoracic radiotherapy. Prophylactic cranial irradiation should be considered for patients ...